Stay updated on Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page
- Check6 days agoChange DetectedThe page history now shows revision label v3.3.2 replacing v3.3.1, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedA new revision entry v3.3.1 was added and the v3.2.0 entry was removed from the history.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoval of the site-wide notice about government funding and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check34 days agoChange DetectedOld and new screenshots show the same version entries with no substantive changes to the study data, indicating a UI/visual refresh rather than content updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and guidance for users.SummaryDifference10%

- Check70 days agoChange DetectedPage now shows updated revision (v3.1.0), current recruitment/status dates, and study status; older protocol completion statement and older revision have been removed.SummaryDifference3%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.